Effectiveness of ChAdOx1 nCOV-19 Vaccine: Experience of a tertiary care institute

BACKGROUND: The first dose of the ChAdOx1 nCoV- 19 Corona Virus Vaccine (Covishield) was administered to the eligible beneficiaries of tertiary care institute of Western Maharashtra on 16 Jan 21 and in the past three months almost 97% of the staff has been vaccinated. The present study analyses the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med J Armed Forces India
Main Authors: Bobdey, Saurabh, Kaushik, S.K., Sahu, Rajesh, Naithani, Nardeep, Vaidya, Rajesh, Sharma, Mithun, Vashishtha, Kundan, Yadav, A.K., Sen, Sourav, Karade, Santosh
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313083/
https://ncbi.nlm.nih.gov/pubmed/34334893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2021.06.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados